IL-21 variants

Details for Australian Patent Application No. 2006237329 (hide)

Owner Novo Nordisk A/S

Inventors Madsen, Dennis; Bodensgaard, Kent; Hjorth, Siv Annegrethe

Agent Shelston IP

Pub. Number AU-B-2006237329

PCT Pub. Number WO2006/111524

Priority PA 2005 00562 18.04.05 DK

Filing date 18 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 12 April 2012

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/111524 Priority application(s): WO2006/111524

12 April 2012 Application Accepted

  Published as AU-B-2006237329

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006237346-Expression cassettes for seedpreferential expression in plants

2006237320-A customer centric travel system